Ever since Medicare transitioned payment for outpatient drugs from the Average Wholesale Price (AWP) model to Average Sales Price (ASP), effectively decreasing the profits to be made on the drugs, a lot of attention has been paid to Medical Oncologists' income. Is it decreasing? By how much? How are they responding? With commercial payers also applying downward pressure, these questions continue to be asked. The other day I thought it would be good to actually see what the data says, so I pulled the past four years of MGMA data and here's what I found.
Hematologist/Oncologist Income - MGMA
Tracking Medical Oncologists' Salaries
A colleague just forwarded on this article
to me, about the new proton beam center slated for Manhattan and it reminded me that there has been some new activity in the market of late that might be worth an update. About two years ago, all of the discussion was about who was going to make the investment - would folks wait for the cheaper, smaller platforms or go big, and go now. Now, many of those sites have been under construction for a while and are now up and running - specifically Oklahoma City
and Hampton University
, and the Central DuPage's
should be up and running soon. The big question is always how these centers will impact their local market - we should begin to see how that plays out soon.
Across 2006 and 2007, LiveStrong conducted a survey designed to identify and quantify post-treatment cancer survivors' needs. While the survey results have been presented at multiple conferences, they just released them in report format earlier this summer.
The survey asked about survivors' physical, emotional and practical needs. Among respondent's physical concerns:
- 59% reported problems with energy and rest
- 55% reported problems with concentration
- 46% reported problems with sexual functioning
- 42% reported problems with neuropathy
- 34% reported problems with pain
Notably, the majority of respondents said that they had not received care for these physical concerns.
LiveStrong Survey Identifies Post-Treatment Survivors' Needs